FBXO32 and stroke disorder: Precisely, muscle‐specific SirT1 gain‐of‐function mice are resistant to the stroke‐induced muscle atrophy as evidenced by no changes in the muscle mass and the expression levels of Atrogin‐1 and MuRF‐1 genes.